AbC-19 rapid antibody test
This article needs more medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "AbC-19 rapid antibody test" – news · newspapers · books · scholar · JSTOR (June 2021) |
The AbC-19 rapid antibody test is an immunological test for COVID-19 exposure developed by the UK Rapid Test Consortium and manufactured by Abingdon Health. It uses a lateral flow test to determine whether a person has IgG antibodies to the SARS-CoV-2 virus that causes COVID-19. The test uses a single drop of blood obtained from a finger prick and yields results in 20 minutes. The sensitivity of this test is 98.03% while the specificity is 99.56%.[1] This test is paired with an easy-to-use mobile app which allows a trained professional to generate an antibody test certificate for storing on a person's smartphone.[1]
See also[edit]
References[edit]
- ^ a b "AbC-19™ | COVID-19 Rapid Antibody Test and Certificate Solution | IgG". Abingdon Health plc. Retrieved 2021-08-02.
External links[edit]
This immunology article is a stub. You can help Wikipedia by expanding it. |
This United Kingdom-related article is a stub. You can help Wikipedia by expanding it. |
This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it. |